MedPath

Evaluation of Resectability of Pancreatic Cancer Using Low kVp CT

Not Applicable
Conditions
Diagnoses Disease
Interventions
Diagnostic Test: contrast enhanced computed tomography
Registration Number
NCT03895177
Lead Sponsor
Seoul National University Hospital
Brief Summary

The aim of this study is to investigate usefulness of low kVp high mAs computed tomography in evaluation of pancreatic cancer resectability.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
147
Inclusion Criteria
    1. age between 20 year-old and 85 year-old 2. patient with pancreatic cancer detected on standard CT scan using 120 kVp that obtained within one month 3. consider surgical resection for pancreatic cancer treatment 4. patients who can undergo contrast enhanced CT scan
Exclusion Criteria
    1. history of severe adverse reaction to iodine contrast 2. less than 60 of estimated GFR

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
low kVp high mAs CT groupcontrast enhanced computed tomographydoing pancreatic CT with 80 kVp tube current with more than 500 mA tube current for the evaluation of pancreatic cancer resectability
Primary Outcome Measures
NameTimeMethod
accuracy of low kVp CT to assess R0 resection of pancreatic cancer2 weeks after surgery

Pancreastic cancer resectability

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

Hallym University Sacred Heart Hospital

🇰🇷

Anyang, Korea, Republic of

Korea National Cancer Center

🇰🇷

Goyang-si, Kyung-gi Do, Korea, Republic of

Severance Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Asan medical Center

🇰🇷

Seoul, Korea, Republic of

Korea University Guro Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath